Jane Street’s Roivant Sciences ROIV Stock Holding History

Jane Street’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.72M	Sell	134,200 -139,500	-51%	-$3.58M	﹤0.01%	3976
2025 Q4	$5.94M	Buy	273,700 +13,800	+5%	+$272K	﹤0.01%	2973
2025 Q3	$3.93M	Buy	259,900 +238,000	+1,087%	+$2.95M	﹤0.01%	3783
2025 Q2	$247K	Sell	21,900 -4,200	-16%	-$45.5K	﹤0.01%	8177
2025 Q1	$263K	Sell	26,100 -16,600	-39%	-$180K	﹤0.01%	8019
2024 Q4	$505K	Sell	42,700 -219,100	-84%	-$2.59M	﹤0.01%	6760
2024 Q3	$3.02M	Buy	261,800 +215,800	+469%	+$2.46M	﹤0.01%	3703
2024 Q2	$486K	Sell	46,000 -12,400	-21%	-$136K	﹤0.01%	7061
2024 Q1	$616K	Sell	58,400 -173,000	-75%	-$1.87M	﹤0.01%	6292
2023 Q4	$2.6M	Sell	231,400 -317,400	-58%	-$3.09M	﹤0.01%	3865
2023 Q3	$6.41M	Buy	+548,800	New	+$6.2M	﹤0.01%	2286

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's ROIV Position: Q1 2026 in Review

Jane Street reduced its Roivant Sciences (ROIV) stake by 22% in Q1 2026, selling an estimated $7.47M and leaving 1,020,707 shares worth $28.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

Jane Street first reported a position in ROIV in Q1 2022 and has held it in 16 quarters since. The position peaked at $41.5M in Q3 2025. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

Jane Street held 1,020,707 shares of Roivant Sciences worth $28.3M as of Q1 2026.
Jane Street sold 290,878 Roivant Sciences shares in Q1 2026, an estimated $7.47M.
Roivant Sciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #1489 holding.
Jane Street first reported a position in Roivant Sciences in Q1 2022 and has held it in 16 quarters since.
Jane Street's Roivant Sciences position peaked at $41.5M in Q3 2025.
440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.